companydata.dkcompanydata.dk

Drug Development Consulting Holding ApS: Financial statements 2024

CVR: 42285722

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Drug Development Consulting Holding ApS (CVR 42285722) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -116,000 and a net result of DKK -13,302,000 compared with DKK -9,376,330 the year before. Equity in the 2024 report amounted to DKK 79,145,000. The solvency ratio was 100%. The company had 146 employees in the financial year.

Gross Profit
DKK -116,000
Profit/Loss
DKK -13,302,000
Equity
DKK 79,145,000
Total Assets
DKK 79,167,000
Employees
146

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--116K-13.3M79.1M146
2023--53K-9.4M70.5M164
2022--58K-11.9M72M184

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Registered as owner of Drug Development Consulting Holding ApSSep 3, 2024

As of September 3, 2024, is registered as an owner of Drug Development Consulting Holding ApS with an ownership share of 66%.

Drug Development Consulting Holding ApS: The 2023 annual report is outMay 2, 2024

Drug Development Consulting Holding ApS has published its annual report for 2023. Gross profit came to DKK -53,330, and the net result was DKK -9,376,330.

Mette Kirstine Agger leaves the board of Drug Development Consulting Holding ApSApr 25, 2024

As of April 25, 2024, Mette Kirstine Agger has left the board of directors of Drug Development Consulting Holding ApS.

About Drug Development Consulting Holding ApS

Drug Development Consulting Holding ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by DDC Mørk Holding ApS and GHS III Midco B.V.. According to the 2025 annual report, the company had an average of 122 employees. In 2025, the company reported a gross profit of DKK -92,000 and a net result of DKK -61,449,000 compared with DKK -13,302,000 the year before. Equity in the 2025 report amounted to DKK 32,586,000.

Source: annual report 2025, Danish Business Authority

Other financial years